References
- Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003; 361(9358): 681-689.1260618510.1016/S0140-6736(03)12567-6
- O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373(9678): 1891-1904.1940316410.1016/S0140-6736(09)60327-5
- Cutting GR. Cystic fibrosis genetics: From molecular understanding to clinical application. Nat Rev Genet. 2015; 16(1): 45-56.10.1038/nrg384925404111
- Castellani C, Cuppens H, Macek Μ Jr, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008; 7(3): 179-196.1845657810.1016/j.jcf.2008.03.009
- Dequeker Ε, Stuhrmann Μ, Morris MA, Casals Τ, Castellani C, Claustres M, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations. Eur J Hum Genet. 2009; 17(1): 51-65.1868555810.1038/ejhg.2008.136
- Viviani L, Zolin A, Mehta A, Olesen HV. The European Cystic Fibrosis Society Patient Registry: Valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis. 2014; 9(1): 81-94.2490805510.1186/1750-1172-9-81
- Maiuri L, Raia V, Kroemer G. Strategies for the etiological therapy of cystic fibrosis. Cell Death Differ. 2017; 24(11): 1825-1844.10.1038/cdd.2017.12628937684
- Noveski P, Madjunkova S, Mircevska M, Plaseski T, Filipovski V, Plaseska-Karanfilska D. SNaPshot assay for the detection of the most common CFTR mutations in infertile men. PloS One. 2014; 9(11): ell2498.
- Fustik S, Jakovska T, Plaseska-Karanfilska D. Hyponatremic dehydration and metabolic alkalosis as dominant manifestation in cystic fibrosis infants with mild phenotype – a case series. Srpski Arhiv za Celokupno Lekarstvo. 2018; 146(9-10): 581-583.10.2298/SARH170811053F
- Simova L, Williams C, Efremov GD, Gordova-Muratovska A, Sustic S, Watson EK, et al. δF508 frequency and associated haplotypes near the cystic fibrosis locus in the Yugoslav population. Hum Genet. 1990; 85(4): 432-433.10.1007/BF02428301
- Petreska L, Koceva S, Plaseska D, Chernick M, Gordova-Muratovska A, Fustic S, et al. Molecular basis of cystic fibrosis in the Republic of Macedonia. Clin Genet. 1998; 54(3): 203-209.9788722
- Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M, Savic J, Minic P, et al. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis. Genet Test. 2004; 8(3): 276-280.10.1089/gte.2004.8.27615727251
- Festini F, Taccetti G, Repetto T, Mannini C, Neri S, Bisogni S, et al. Incidence of cystic fibrosis in the Albanian population. Pediatr Pulmonol. 2008; 43(11): 1124-1129.10.1002/ppul.2092018972414
- Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis in Greece: Molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet. 2003; 63(5): 400-409.10.1034/j.1399-0004.2003.00067.x12752573
- Dobra R, Edmondson C, Hughes D, Martin I, Davies JC. Potentiators and correctors in paediatric cystic fibrosis patients: A narrative review. Paediatr Drugs. 2018; 20(6): 555-566.10.1007/s40272-018-0315-z30328089